Vijayakumar, Sanahan
Alberstein, Robert G.
Zhang, Zhiyin
Lu, Yi-Sheng
Chan, Adriano
Wahl, Charlotte E.
Ha, James S.
Hunka, Deborah E. http://orcid.org/0009-0008-6567-9022
Boss, Gerry R.
Sailor, Michael J. http://orcid.org/0000-0002-4809-9826
Tezcan, F. Akif http://orcid.org/0000-0002-4733-6500
Funding for this research was provided by:
National Science Foundation (DMR-2011924)
ODNI | Intelligence Advanced Research Projects Activity (2018-18071700005)
U.S. Department of Energy (DE-SC0003844, DE-SC0019288)
Article History
Received: 27 November 2023
Accepted: 12 July 2024
First Online: 27 July 2024
Competing interests
: MJS is a scientific founder (SF), member of the Board of Directors (BOD), Advisory Board (AB), Scientific Advisory Board (SAB), acts as a paid consultant (PC) or has an equity interest (EI) in the following: Aivocode, Inc (AB, EI); Bejing ITEC Technologies (SAB, PC); Hinalea Imaging (EI); Lisata Therapeutics (EI); Illumina (EI), Matrix Technologies (EI); NanoVision Bio (SAB, EI); Precis Therapeutics (SF, BOD, EI), Quanterix (EI), Spinnaker Biosciences, Inc. (SF, BOD, EI); TruTag Technologies (SAB, EI); and Well-Healthcare Technologies (SAB, PC). Although one or more of the grants that supported this research has been identified for conflict-of-interest management based on the overall scope of the project and its potential benefit to the companies listed, the research findings included in this publication may not necessarily relate to their interests. The terms of these arrangements have been reviewed and approved by the University of California, San Diego, in accordance with its conflict-of-interest policies. The remaining authors declare no competing interests.